Revolution Medicines (RVMD) Depreciation & Amortization (CF) (2019 - 2023)
Revolution Medicines (RVMD) posted Depreciation & Amortization (CF) of $1.2 million for Q2 2023, up 1.49% on a QoQ basis from $1.2 million in Q1 2023, and up 31.36% year-over-year from $931000.0 in Q2 2022.
Powered by 
Analysis
Revolution Medicines (RVMD) Depreciation & Amortization (CF) (2019 - 2023) Analysis & Trends
Revolution Medicines has reported Depreciation & Amortization (CF) for 5 years, with the latest figure at $1.2 million in Q2 2023.
- On a quarterly basis, Depreciation & Amortization (CF) rose 31.36% year-over-year to $1.2 million in Q2 2023; TTM through Mar 2024 was $1.2 million, a 71.58% decrease from a year earlier, with the FY2023 full-year figure at $5.0 million, up 25.0% from the prior year.
- Depreciation & Amortization (CF) was $1.2 million for Q2 2023 at Revolution Medicines, up from $1.2 million in the prior quarter.
- The five-year high for Depreciation & Amortization (CF) was $1.2 million in Q2 2023, with the low at $526000.0 in Q1 2019.
- Average Depreciation & Amortization (CF) over 5 years is $800666.7, with a median of $733500.0 recorded in 2020.
- The sharpest annual moves came in 2021 and 2022: Depreciation & Amortization (CF) gained 6.17% in 2021, then surged 41.3% in 2022.
- Over 5 years, Depreciation & Amortization (CF) stood at $598000.0 in 2019, then advanced by 12.71% to $674000.0 in 2020, then increased by 23.59% to $833000.0 in 2021, then surged by 41.3% to $1.2 million in 2022, then increased by 3.91% to $1.2 million in 2023.
- The last three Depreciation & Amortization (CF) figures came in at $1.2 million (Q2 2023), $1.2 million (Q1 2023), and $1.2 million (Q4 2022), per Business Quant data.
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Dep. & Amort. (Qtr) |
|---|---|---|---|---|---|
| 1 | Johnson & Johnson | 649.01 Bn | 628.25 Bn | 17.26 Bn | 1.96 Bn |
| 2 | AbbVie | 468.55 Bn | 462.03 Bn | 12.70 Bn | - |
| 3 | Merck | 365.49 Bn | 358.40 Bn | 12.21 Bn | - |
| 4 | Novartis Ag | 272.39 Bn | 265.10 Bn | 11.24 Bn | - |
| 5 | Astrazeneca | 253.18 Bn | 247.96 Bn | 12.86 Bn | 1.93 Bn |
| 6 | Amgen | 219.53 Bn | 205.54 Bn | 7.24 Bn | 1.11 Bn |
| 7 | Gilead Sciences | 187.85 Bn | 184.59 Bn | 6.22 Bn | - |
| 8 | Pfizer | 160.56 Bn | 149.16 Bn | 10.94 Bn | 1.62 Bn |
| 9 | Vertex Pharmaceuticals | 130.81 Bn | 122.96 Bn | 2.84 Bn | 56.50 Mn |
| 10 | Revolution Medicines | 40.86 Bn | 40.86 Bn | - | - |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Jun 30, 2023 | 1.22 Mn |
| Mar 31, 2023 | 1.21 Mn |
| Dec 31, 2022 | 1.18 Mn |
| Sep 30, 2022 | 991,000.00 |
| Jun 30, 2022 | 931,000.00 |
| Mar 31, 2022 | 901,000.00 |
| Dec 31, 2021 | 833,000.00 |
| Sep 30, 2021 | 793,000.00 |
| Jun 30, 2021 | 803,000.00 |
| Mar 31, 2021 | 671,000.00 |
| Dec 31, 2020 | 674,000.00 |
| Sep 30, 2020 | 665,000.00 |
| Jun 30, 2020 | 640,000.00 |
| Mar 31, 2020 | 632,000.00 |
| Dec 31, 2019 | 598,000.00 |
| Sep 30, 2019 | 605,000.00 |
| Jun 30, 2019 | 544,000.00 |
| Mar 31, 2019 | 526,000.00 |
API Access
Revolution Medicines Depreciation & Amortization (CF) API
Pull this series into your own models, spreadsheets and apps with the Business Quant
Historical Metrics API. The request below matches the chart above — change the
frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.
https://data.businessquant.com/historic?slug=depreciation-and-amortization-cf&ticker=RVMD&period=max&api_key=YOUR_API_KEYimport requests
url = "https://data.businessquant.com/historic"
params = {"slug": "depreciation-and-amortization-cf", "ticker": "RVMD", "period": "max", "api_key": "YOUR_API_KEY"}
data = requests.get(url, params=params).json()const res = await fetch("https://data.businessquant.com/historic?slug=depreciation-and-amortization-cf&ticker=RVMD&period=max&api_key=YOUR_API_KEY");
const data = await res.json();